Abu, Nashmia D.

HRN: 23-29-39  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2023
CEFUROXIME 750MG (VIAL)
07/06/2023
07/12/2023
IVT
300mg IVT
Q8
UTI; URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Urinary TractURTI    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: